Simplify Logo

Full-Time

Associate Product Manager

Studies and Sample Management

Confirmed live in the last 24 hours

Moderna

Moderna

5,001-10,000 employees

Develops mRNA-based medicines for health

Healthcare
Biotechnology

Junior, Mid

Cambridge, MA, USA

70/30 work model requires 70% in-office presence.

Category
Product Management
Product
Required Skills
Agile
Data Science
Management
Requirements
  • Bachelor's degree in a Biology, Chemistry, Biochemistry, (or related scientific field) or computer science.
  • 2+ years of experience in product management, specifically in digital products within the biotechnology or pharmaceutical industries.
  • Demonstrated success in leading product development in a research-focused field.
  • Strong understanding of Agile development methodologies and product lifecycle management.
Responsibilities
  • Develop and articulate a clear vision for software products that support scientific research, aligning product strategies with business objectives and scientific goals.
  • Lead cross-functional teams comprising of software engineers, discovery science team representatives, and data science leads, to deliver products that transform scientific data into actionable insights.
  • Manage the product lifecycle from concept through development, deployment, and refinement, ensuring the products meet the high standards required in a scientific research environment.
  • Craft and maintain product roadmaps, prioritize product features, and balance market needs with practical implementation strategies.
  • Translate complex scientific needs into detailed technical requirements that drive software development, facilitating the formulation and delivery of high-value solutions.
  • Establish and monitor key performance indicators to evaluate product effectiveness and impact on research outcomes.
  • Engage regularly with stakeholders to ensure continuous alignment of the product with business needs and user expectations.
  • Champion agile methodologies, encouraging iterative development and responsive adjustments based on feedback and changing requirements.
  • Serve as the primary communicator and liaison between the scientific SMEs consuming our products and the Digital team generating them, ensuring clear understanding and collaboration across the organization.

Moderna focuses on developing medicines using messenger RNA (mRNA), which is a molecule that provides instructions for cells to produce proteins essential for various biological functions. Their approach involves creating a new class of medicines that leverage mRNA to potentially enhance the discovery, development, and manufacturing of drugs. Unlike traditional methods, which often rely on proteins or other biological materials, Moderna's use of mRNA allows for a more versatile and efficient way to create treatments. The company's goal is to improve patient outcomes by harnessing the power of mRNA to address a wide range of health issues.

Company Stage

Grant

Total Funding

$5.9B

Headquarters

Cambridge, Massachusetts

Founded

N/A

Growth & Insights
Headcount

6 month growth

3%

1 year growth

8%

2 year growth

55%
Simplify Jobs

Simplify's Take

What believers are saying

  • Moderna's expansion into combination vaccines and autoimmune therapies showcases its potential for diversified revenue streams and market leadership.
  • The company's continuous innovation and FDA approvals for updated COVID-19 vaccines highlight its resilience and adaptability in a rapidly changing market.
  • Moderna's educational initiatives, like the free mRNA course, position it as a thought leader and advocate for mRNA technology.

What critics are saying

  • The collapse in demand for COVID-19 vaccines could significantly impact Moderna's revenue and growth prospects.
  • Ongoing class action lawsuits alleging securities fraud could damage Moderna's reputation and financial stability.

What makes Moderna unique

  • Moderna is pioneering the use of mRNA technology to create a new class of medicines, setting it apart from traditional pharmaceutical companies.
  • The company's focus on mRNA as the 'software of life' allows for rapid development and manufacturing of vaccines and therapies, unlike conventional methods.
  • Moderna's ability to secure regulatory approvals for mRNA vaccines beyond COVID-19, such as for RSV, demonstrates its leadership in mRNA technology.